date,title,source
Oct-18-18,Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients Perspective,GlobeNewswire
Oct-23-18,"Zosano Treats over 4,000 Migraines and Reaches an Important Goal in M207-ADAM Long-term Safety Study",GlobeNewswire
Oct-25-18,"Recent Analysis Shows Stellus Capital Investment, Nuance Communications, ProPetro Holding, Sanchez Energy, Granite Point Mortgage Trust, and Zosano Pharma Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-07-18,Zosano Pharma to Host Conference Call on Third Quarter 2018 Financial Results and Provide Operational Update,GlobeNewswire
Nov-14-18,Zosano Pharma Reports Third Quarter 2018 Financial Results and Operational Update,GlobeNewswire
Dec-12-18,Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta for M207,GlobeNewswire
Jan-16-19,"Zosano Appoints Linda Grais M.D., J.D. to Board of Directors",GlobeNewswire
Jan-31-19,Zosano Announces Publication of Positive Data on Qtryptas Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines,GlobeNewswire
Feb-21-19,Watch These Tech Stocks Push The Limit,ACCESSWIRE
Feb-21-19,What Kind Of Shareholder Owns Most Zosano Pharma Corporation (NASDAQ:ZSAN) Stock?,Simply Wall St.
Feb-21-19,Zosano Announces Completion of the Final Milestone in the Long-Term Safety Study of Qtrypta for the Acute Treatment of Migraine Disease,GlobeNewswire
Feb-22-19,Four Healthcare Stocks Looking to Close Out a Strong Week,ACCESSWIRE
Feb-22-19,FDA Events Can Send Stocks Soaring: Here's One That Absolutely No One Is Talking About,ACCESSWIRE
Feb-25-19,"Detailed Research: Economic Perspectives on Zosano Pharma, Appian, Ross Stores, Alleghany, ZAGG, and Lindsay  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Mar-07-19,Zosano Pharma to Host Conference Call on Fourth Quarter and Full Year 2018 Financial Results and Provide Operational and Strategic Update,GlobeNewswire
Mar-11-19,Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference,GlobeNewswire
Mar-14-19,Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results,Business Wire
Mar-14-19,Zosano Pharma Corp. to Host Earnings Call,ACCESSWIRE
Apr-08-19,Zosano Pharma Announces Proposed Public Offering of Common Stock,GlobeNewswire
Apr-09-19,Zosano Announces Pricing of Public Offering of Common Stock,GlobeNewswire
Apr-16-19,Zosano Announces the Publication of an Analysis of Acute Treatments for Migraine in Headache: The Journal of Head and Face Pain,GlobeNewswire
